Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for renal protection during nephron-sparing surgery
ChiCTR2100041967Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Nephroma comparing tadalafil with Control: placebo (2 arms). Primary endpoint: α1 microglobulin. Started Jan 2021; status: recruiting.
02
Drugs
tadalafil
03
Conditions
Nephroma
Beyond the preview
Go deeper on ChiCTR2100041967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041967.